View ValuationWesfarmers 향후 성장Future 기준 점검 2/6Wesfarmers (는) 각각 연간 5.6% 및 4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 38.4% 로 예상됩니다.핵심 정보5.6%이익 성장률5.69%EPS 성장률Multiline Retail 이익 성장16.8%매출 성장률4.0%향후 자기자본이익률38.43%애널리스트 커버리지Good마지막 업데이트13 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Feb 20Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2025 , Payable on March 31, 2026Wesfarmers Limited announced dividend of AUD 0.95000000 per share for the six months ended December 31, 2025. Record date is February 25, 2026. Ex-date is February 25, 2025. Payment date is March 31, 2026.공시 • Jan 09Wesfarmers Limited to Report Fiscal Year 2026 Results on Aug 27, 2026Wesfarmers Limited announced that they will report fiscal year 2026 results on Aug 27, 2026공시 • Dec 07Wesfarmers Limited to Report First Half, 2026 Results on Feb 19, 2026Wesfarmers Limited announced that they will report first half, 2026 results on Feb 19, 2026공시 • Nov 03+ 1 more updateWesfarmers Limited Announces a Special Dividend, Payable on December 4, 2025Wesfarmers Limited announced a special dividend of AUD 0.40 per share. The record date for the dividend is November 6, 2025, the ex-dividend date is November 5, 2025, and the payment date is December 4, 2025.공시 • Oct 31Wesfarmers Limited Announces Cessation of Jennifer Anne Westacott as Director, Effective 30 October 2025Wesfarmers Limited announced cessation of Jennifer Anne Westacott as director. Date that director ceased to be director: 30 October 2025.공시 • Sep 05Wesfarmers Limited, Annual General Meeting, Oct 30, 2025Wesfarmers Limited, Annual General Meeting, Oct 30, 2025. Location: at the perth convention and exhibition centre, mounts bay road, perth, western australia Australia공시 • Aug 30Wesfarmers Limited Announces Board ChangesWesfarmers Limited announced that its Board has resolved to appoint Mr. Ken MacKenzie as Chairman to succeed Michael Chaney from the conclusion of Wesfarmers' 2026 Annual General Meeting (AGM), expected to be held on 29 October 2026. Mr. MacKenzie will join the Board of Wesfarmers on 1 June 2026. Mr. Chaney announced he would retire at the end of his current three-year term. Mr. Chaney's retirement will mark the end of a long and successful career at Wesfarmers, including separate periods in which he has served as Chairman and as Managing Director. He joined Wesfarmers in 1983 as Company Secretary and Administration Manager and became Finance Director in 1984. Mr. Chaney was appointed Managing Director in July 1992 and retired from that position in July 2005. He re-joined the Board as a non-executive director in June 2015, becoming Chairman in November 2015. Mr. MacKenzie has extensive experience as a chairman and senior executive in large, complex businesses operating across multiple industries and jurisdictions. Most recently Mr. MacKenzie was the Chair of BHP Group Limited, from September 2017 to March 2025. Before that, from 2005 to 2015, he served as Managing Director and Chief Executive Officer of Amcor Limited, a global packaging company. Mr. MacKenzie is currently the Chair of Melbourne Business School Limited (since June 2023), a member of the Advisory Board of American Securities Capital Partners LLC (since January 2016) and is a part-time adviser at Barrenjoey (since April 2021).공시 • Aug 28Wesfarmers Limited, Annual General Meeting, Oct 29, 2026Wesfarmers Limited, Annual General Meeting, Oct 29, 2026.공시 • Jul 02Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES).Supagas Holding Pty Ltd agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd. The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025.Damien Roberts of Herbert Smith Freehills acted as a legal advisor to Coregas. As of June 26 ,2025, Wesfarmers announced that all conditions precedent to the sale of Coregas to a subsidiary of Nippon Sanso Holdings Corporation have now been satisfied and sale is now unconditional. The transaction is expected to be completed in July 2025. The sale subject to the receipt of certain consents and approvals, including from the Australian Competition and Consumer Commission and Foreign Investment Review Board, which have now been received. Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) on July 1, 2025. Wesfarmers expects to record a pre-tax profit on sale of approximately AUD 230 million to AUD 260 million, subject to completion adjustments, with this amount to be included in the results for the 2025 financial year. Daniel Coote, Kapil Kumar, Martin Linhart, Pulin Desai and Fady Abi Abdallah of BDO Corporate Finance (QLD) Limited acted as due diligence provider for Supagas Holding Pty Ltd.공시 • Mar 08Wesfarmers Announces to Wind Up BPI No 1 Pty Ltd. Property Structure in September 2025Wesfarmers announced that it will wind up the BPI No 1 Pty Ltd. property structure in September 2025. This will involve Wesfarmers taking full ownership of the fifteen Bunnings warehouse properties ("the properties") that are currently in the BPI structure. In August 2013, Wesfarmers established BPI as a wholly owned, special purpose vehicle to facilitate the sale and leaseback of the properties via a securitised lease transaction. The sale and leaseback was funded primarily from the issuance by BPI of twelve-year senior secured notes to investors. Subject to the independent valuation, Wesfarmers is expected to record a one-off pre-tax profit associated with the transaction of between $80 million and $130 million in the 2025 financial year. The one-off impact to Wesfarmers' earnings reflects the expected fair value uplift associated with the properties and the unwind of the property structure. Wesfarmers will undertake a strategic review of the properties, which will include exploring a range of capital management options once the BPI structure is unwound.공시 • Dec 21Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million.Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd. The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025.공시 • Nov 20+ 1 more updateWesfarmers Limited to Report Fiscal Year 2025 Results on Aug 28, 2025Wesfarmers Limited announced that they will report fiscal year 2025 results on Aug 28, 2025공시 • Sep 03Wesfarmers Limited Announces Resignation of Robert Geoffrey Scott as DirectorWesfarmers Limited announced the resignation of Robert Geoffrey Scott as director. Date of last notice is on 24 May 2024.공시 • Aug 15Macquarie and Wesfarmers Reportedly Join the Race for $3 Billion I-MED SaleWesfarmers Limited (ASX:WES) and Macquarie Group Limited (ASX:MQG) are the latest names to emerge as a keen competitors for the $3 billion diagnostic imaging business I-MED Holdings Pty Limited, which is about to hit the market. It comes after Wesfarmers is understood to have carried out detailed analysis of I-MED, as it focuses on the healthcare industry for acquisitions. No doubt acquisitions in healthcare will be discussed when Wesfarmers, which owns retail brands including Target, Kmart and Officeworks, reports its full year results on August 29. Meanwhile, Macquarie would look at I-MED through its infrastructure arm Macquarie Asset Management, and is believed to be keen to get a partner to assess the opportunity. DataRoom revealed that Morgan Stanley was about to be hired to sell I-MED, with Bain Capital and Morgan Stanley Infrastructure Partners interested suitors. Jefferies Australia is also now advising. A number of other global private equity firms are also lining up to take a look, say sources.공시 • Aug 12Private Equity Reportedly Pursues RamsayA European private equity firm is understood to be running the ruler over the $10 billion Ramsay Health Care Limited (ASX:RHC), with an eye to becoming the second group in two years to launch a buyout proposal for the nation's largest private hospital operator. Ramsay last week flagged that it would deliver weaker-than-expected earnings for the full year as it wrote down the value of its European operation. The hospital operator, which is scheduled to release its full-year results on August 30, told the ASX last Monday that its underlying net profit was expected to be in the range of $265 million to $270 million, compared with $278.2 million the previous year. Ramsay was considered a takeover target earlier this year, with the Perth-based conglomerate Wesfarmers known to be running the ruler over the business some time ago. It is understood that Wesfarmers Limited (ASX:WES), which recently appointed Ramsay's former chief operating officer Kate Munnings, to its board carried out extensive and detailed work on a potential buyout of Ramsay and an acquisition of the country's largest diagnostic imaging provider I-MED, which is expected to be put on the block next month for about $3 billion through Morgan Stanley and Jefferies. However, Wesfarmers thought Ramsay would have to be far cheaper before it would make its move - despite Ramsay's share price being at its lowest level in a decade, about a third cheaper than it was after Kohlberg Kravis Roberts bid for the business in 2022. Some think the European suitor may be CVC, while Partners Group, which is also based in Europe, has looked at Australian healthcare company Healius, and EQT could also be an acquirer. Other European funds that invest in healthcare include Permira, PAI and Intermediate Capital. Some think a company with real estate expertise would be the most likely to have interest because of Ramsay's lucrative portfolio of hospital assets in Australia. There's also a view that any deal involving Ramsay would unfold after it has demerged or sold its Ramsay Sante operation in Europe. Ramsay, whose David Thodey-led board recently appointed former Woolworths executive Natalie Davis as chief executive to replace Craig McNally, has been trying to find a solution for that part of the company, which has lagged in performance. Ramsay Health Care owns 52.79% of Ramsay Sante, the second-largest private care provider in Europe, and a sale would help to reduce its $4.7 billion of debt. Buyers are not interested in the whole business, but it could try to sell a stake.공시 • May 02Wesfarmers Limited Announces Executive ChangesWesfarmers Limited announced that Ian Hansen, Managing Director of Wesfarmers Chemicals, Energy and Fertilisers (WesCEF) has advised of his intention to retire in November 2024. Mr. Hansen will remain with WesCEF and Wesfarmers in an advisory capacity to ensure a smooth transition and provide ongoing support on key projects, including the Group's lithium business, where he will remain Chairman of Covalent Lithium. Mr. Hansen will be succeeded by Aaron Hood, WesCEF's Chief Operating Officer. Prior to his current role Mr. Hood held other senior executive positions within the Group, including Chief Financial Officer of WesCEF and Executive General Manager of Business Development at Wesfarmers. He is also a director of the Covalent Lithium joint venture. Wesfarmers Managing Director Rob Scott said Mr. Hood's skills and experience made him a logical successor to Mr. Hansen. Mr. Hood has been appointed Deputy Managing Director of WesCEF effective 2 May 2024 and will also retain responsibilities as Chief Operating Officer until he commences as the Managing Director of WesCEF in November 2024.공시 • Apr 24Wesfarmers Reportedly Runs the Ruler over Ramsay Health CareThe $74 billion Australian listed conglomerate Wesfarmers Limited (ASX:WES) is understood to have been carrying out detailed work in recent months, weighing up the merits of buying Ramsay Health Care Limited (ASX:RHC). It is understood that Wesfarmers - which owns Target, Kmart, Officeworks and other industrial and healthcare assets - is interested in securing Ramsay's Australian business. However, with its shares performing strongly and a $74 billion market value, it's not inconceivable that Wesfarmers buys all of the $12 billion private hospital operator and sells off the international assets to other parties. Some believe that the timing could now be right for Wesfarmers to embark on its next major acquisition, after bedding down the 2022 purchase of Priceline pharmacy chain owner Australian Pharmaceutical Industries for $763 million to seed its healthcare unit. Whether it remains serious about a deal remains unclear. Wesfarmers is usually assessing the acquisition of a handful of targets at any given time, and maintains an active mergers and acquisitions team. It has looked at plenty of opportunities in the past before opting to walk away, and can treat targets as simply a due diligence exercise. Another possibility is that it could simply be weighing up a tilt at Ramsay's pharmacy unit, which it has expressed interest in before. Still, Wesfarmers' share price has rallied since the start of this year so it could take advantage of that, while the healthcare sector has been struggling with high costs and staff shortages, dampening the performance of Australian listed stocks trading in the space, including Ramsay. Also weighing in Wesfarmers' favour is the fact that Ramsay's shareholders have been unhappy with the company's performance since Kohlberg Kravis Roberts walked away from a bid in 2022, causing its share price to tumble, and the could be more open to a buyout. The David Thodey-chaired Ramsay is believed to be thinking about a potential exit from its European hospital owner, Ramsay Sante, in which it has a 52.79% stake. DataRoom understands that Wesfarmers has carried out work on all aspects of the Ramsay business, including its real estate, and has been speaking to healthcare funds and industry figures.공시 • Feb 17Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2023, Payable on March 27, 2024Wesfarmers Limited announced dividend for the six months ended December 31, 2023 of AUD 0.91000000 per share. Record date is February 21, 2024. Ex-date is February 20, 2024. Payment date is March 27, 2024.공시 • Dec 05+ 2 more updatesWesfarmers Limited, Annual General Meeting, Oct 31, 2024Wesfarmers Limited, Annual General Meeting, Oct 31, 2024.공시 • Sep 07TPG Capital Reportedly Tests Buyer Interest for the $3.5 Billion-Plus GreencrossSpeculation is mounting that TPG Capital, L.P. is testing buyer interest for the $3.5 billion-plus Petbarn owner Greencross Limited and some are pointing to Wesfarmers Limited (ASX:WES) as the potential suitor. Working on a potential sale of the business, which owns veterinary clinics and a trans-Tasman pet care retail business, is investment bank Jefferies LLC, and there is a view that the $60 billion listed Perth-based Wesfarmers is showing some interest. The question is whether TPG would sell the company as a whole or just the interest that it retained after offloading 45% to AustralianSuper and The Healthcare of Ontario Pension Plan. That deal last year valued the business at $3.5 billion, and since then, Greencross has purchased Habitat Pet Supplies, a Melbourne-based pet store chain with five stores that it plans to merge with its Petbarn and Animates retail business. The logic is all there for Wesfarmers to buy Greencross. The question is whether it would buy off TPG - expected to have overly enthusiastic expectations on price. Yet TPG has already pocketed $1.57 billion through its sell down so perhaps the price tag won't be that large after all. Wesfarmers, which did not comment on whether it was weighing an acquisition, would be familiar with the business given it looked at Greencross when Credit Suisse and Morgan Stanley ran a sale process in 2021.공시 • Aug 25Wesfarmers Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on October 5, 2023Wesfarmers Limited announced dividend of AUD 1.03 per share for the six months ended June 30, 2023. Ex-date is August 30, 2023. Record date is August 31, 2023. Payment date is October 5, 2023.공시 • Jun 27Wesfarmers Limited Announces Management ChangesWesfarmers Limited announced that Vicki Robinson has advised of her intention to retire as Company Secretary, effective 30 October 2023, to focus on non-executive opportunities. Ms. Robinson will be succeeded as Company Secretary and as a member of the Wesfarmers Leadership Team by Sheldon Renkema. Mr. Renkema joined Wesfarmers in 2007 and is currently General Manager of Business Development for Wesfarmers Chemicals, Energy and Fertilisers, having previously held senior positions leading the corporate and retail legal teams within the Wesfarmers Corporate Solicitors Office. Wesfarmers Managing Director, Rob Scott, thanked Ms. Robinson for her significant contribution to Wesfarmers over the last 20 years and congratulated Mr. Renkema on his appointment.공시 • May 09Wesfarmers Reportedly Among Suitors for Alinta AssetsWesfarmers Limited (ASX:WES) is understood to be among the suitors looking to acquire Alinta Energy Pty Limited's West Australian assets. First-round bids for the assets are due on May 12 in the Goldman Sachs-run competition. Sources say the motivation of the $58 billion listed conglomerate is to gain additional sources of power, and it would be compelled by the renewable energy component of the offering. Several parties are believed to be lining up for Alinta's business, including Pacific Equity Partners, which owns Zenith Energy, and the business interests of Gina Rinehart, owner of Hancock Energy and Hancock Prospecting. DataRoom understands that working with Hancock on Alinta is Highbury Partnership, which advised on the $4 billion acquisition by Chow Tai Fook of Alinta Energy in 2017 from TPG Capital. Also in the competition are private equity firm EQT Partners AB and Macquarie Group Limited (ASX:MQG), which would partner with another suitor, likely to be BP, which is also looking. Macquarie already partners with BP on its Australian Renewable Energy Hub in the Pilbara. Queensland Investment Corporation is expected to be looking through its Pacific Energy business, while CKI is believed to be bidding through Energy Developments, although the Chinese-owned group may face opposition from the Foreign Investment Review Board. There is also a view that billionaire Andrew Forrest will be around the hoop - either through his Squadron Energy or through Fortescue Metals. Investment bank Citi is mandated by a party, and sources have been pointing to either QIC or Brookfield. Based on the level of interest, some think private equity firms, and possibly APA, will not be competitive on price, going up against parties with a cheaper cost of capital.공시 • Feb 15+ 1 more updateWesfarmers Limited, Annual General Meeting, Oct 26, 2023Wesfarmers Limited, Annual General Meeting, Oct 26, 2023.공시 • Jan 18Wesfarmers Limited to Report Q2, 2023 Results on Feb 15, 2023Wesfarmers Limited announced that they will report Q2, 2023 results on Feb 15, 2023공시 • Oct 19Wesfarmers Limited to Report Fiscal Year 2023 Results on Aug 25, 2023Wesfarmers Limited announced that they will report fiscal year 2023 results on Aug 25, 2023이익 및 매출 성장 예측OTCPK:WFAF.Y - 애널리스트 향후 추정치 및 과거 재무 데이터 (AUD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수6/30/202851,7063,3773,8275,005136/30/202749,4843,1463,4094,936146/30/202647,1922,8462,9324,0441412/31/202546,4223,0623,3124,484N/A9/30/202546,0612,9943,3674,526N/A6/30/202545,7002,9263,4214,568N/A3/31/202545,3532,7633,3004,420N/A12/31/202445,0062,5993,1784,271N/A9/30/202444,5982,5783,3484,433N/A6/30/202444,1892,5573,5184,594N/A3/31/202443,9272,5323,7184,850N/A12/31/202343,6652,5063,9175,106N/A9/30/202343,6082,4863,4044,643N/A6/30/202343,5502,4652,8914,179N/A3/31/202342,5942,4942,1853,448N/A12/31/202241,6382,5231,4792,716N/A9/30/202239,2382,4381,3182,509N/A6/30/202236,8382,3521,1572,301N/A3/31/202235,3822,2781,4062,512N/A12/31/202133,9252,2031,6542,723N/A9/30/202133,9332,2922,0713,053N/A6/30/202133,9412,3802,4873,383N/A3/31/202133,6562,1333,1484,007N/A12/31/202033,3711,8853,8094,631N/A9/30/202032,1091,7543,7444,589N/A6/30/202030,8461,6223,6794,546N/A3/31/202029,8141,8052,8433,704N/A12/31/201928,7811,9872,0062,862N/A9/30/201928,3511,964N/A2,790N/A6/30/201927,9201,940N/A2,718N/A3/31/201927,6291,876N/AN/AN/A12/31/201827,3371,811N/A3,170N/A9/30/201827,0501,610N/A3,625N/A6/30/201826,7631,409N/A4,080N/A12/31/201743,8101,861N/A4,475N/A9/30/201754,3622,311N/A4,351N/A6/30/201764,9132,760N/A4,226N/A3/31/201767,9401,732N/A3,918N/A12/31/201667,436591N/A3,609N/A9/30/201666,709499N/A3,487N/A6/30/201665,981407N/A3,365N/A3/31/201664,9601,432N/A3,640N/A12/31/201563,9392,457N/A3,914N/A9/30/201563,1932,449N/A3,853N/A6/30/201562,4472,440N/A3,791N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: WFAF.Y 의 연간 예상 수익 증가율(5.6%)이 saving rate(3.5%)보다 높습니다.수익 vs 시장: WFAF.Y 의 연간 수익(5.6%)이 US 시장(16.8%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: WFAF.Y 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: WFAF.Y 의 수익(연간 4%)이 US 시장(연간 11.7%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: WFAF.Y 의 수익(연간 4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: WFAF.Y의 자본 수익률은 3년 후 38.4%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YRetail 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/18 20:02종가2026/05/15 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Wesfarmers Limited는 21명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Thomas KierathBarrenjoey Markets Pty LimitedDavid ErringtonBofA Global ResearchDaniel BroerenCGS International18명의 분석가 더 보기
공시 • Feb 20Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2025 , Payable on March 31, 2026Wesfarmers Limited announced dividend of AUD 0.95000000 per share for the six months ended December 31, 2025. Record date is February 25, 2026. Ex-date is February 25, 2025. Payment date is March 31, 2026.
공시 • Jan 09Wesfarmers Limited to Report Fiscal Year 2026 Results on Aug 27, 2026Wesfarmers Limited announced that they will report fiscal year 2026 results on Aug 27, 2026
공시 • Dec 07Wesfarmers Limited to Report First Half, 2026 Results on Feb 19, 2026Wesfarmers Limited announced that they will report first half, 2026 results on Feb 19, 2026
공시 • Nov 03+ 1 more updateWesfarmers Limited Announces a Special Dividend, Payable on December 4, 2025Wesfarmers Limited announced a special dividend of AUD 0.40 per share. The record date for the dividend is November 6, 2025, the ex-dividend date is November 5, 2025, and the payment date is December 4, 2025.
공시 • Oct 31Wesfarmers Limited Announces Cessation of Jennifer Anne Westacott as Director, Effective 30 October 2025Wesfarmers Limited announced cessation of Jennifer Anne Westacott as director. Date that director ceased to be director: 30 October 2025.
공시 • Sep 05Wesfarmers Limited, Annual General Meeting, Oct 30, 2025Wesfarmers Limited, Annual General Meeting, Oct 30, 2025. Location: at the perth convention and exhibition centre, mounts bay road, perth, western australia Australia
공시 • Aug 30Wesfarmers Limited Announces Board ChangesWesfarmers Limited announced that its Board has resolved to appoint Mr. Ken MacKenzie as Chairman to succeed Michael Chaney from the conclusion of Wesfarmers' 2026 Annual General Meeting (AGM), expected to be held on 29 October 2026. Mr. MacKenzie will join the Board of Wesfarmers on 1 June 2026. Mr. Chaney announced he would retire at the end of his current three-year term. Mr. Chaney's retirement will mark the end of a long and successful career at Wesfarmers, including separate periods in which he has served as Chairman and as Managing Director. He joined Wesfarmers in 1983 as Company Secretary and Administration Manager and became Finance Director in 1984. Mr. Chaney was appointed Managing Director in July 1992 and retired from that position in July 2005. He re-joined the Board as a non-executive director in June 2015, becoming Chairman in November 2015. Mr. MacKenzie has extensive experience as a chairman and senior executive in large, complex businesses operating across multiple industries and jurisdictions. Most recently Mr. MacKenzie was the Chair of BHP Group Limited, from September 2017 to March 2025. Before that, from 2005 to 2015, he served as Managing Director and Chief Executive Officer of Amcor Limited, a global packaging company. Mr. MacKenzie is currently the Chair of Melbourne Business School Limited (since June 2023), a member of the Advisory Board of American Securities Capital Partners LLC (since January 2016) and is a part-time adviser at Barrenjoey (since April 2021).
공시 • Aug 28Wesfarmers Limited, Annual General Meeting, Oct 29, 2026Wesfarmers Limited, Annual General Meeting, Oct 29, 2026.
공시 • Jul 02Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES).Supagas Holding Pty Ltd agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd. The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025.Damien Roberts of Herbert Smith Freehills acted as a legal advisor to Coregas. As of June 26 ,2025, Wesfarmers announced that all conditions precedent to the sale of Coregas to a subsidiary of Nippon Sanso Holdings Corporation have now been satisfied and sale is now unconditional. The transaction is expected to be completed in July 2025. The sale subject to the receipt of certain consents and approvals, including from the Australian Competition and Consumer Commission and Foreign Investment Review Board, which have now been received. Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) on July 1, 2025. Wesfarmers expects to record a pre-tax profit on sale of approximately AUD 230 million to AUD 260 million, subject to completion adjustments, with this amount to be included in the results for the 2025 financial year. Daniel Coote, Kapil Kumar, Martin Linhart, Pulin Desai and Fady Abi Abdallah of BDO Corporate Finance (QLD) Limited acted as due diligence provider for Supagas Holding Pty Ltd.
공시 • Mar 08Wesfarmers Announces to Wind Up BPI No 1 Pty Ltd. Property Structure in September 2025Wesfarmers announced that it will wind up the BPI No 1 Pty Ltd. property structure in September 2025. This will involve Wesfarmers taking full ownership of the fifteen Bunnings warehouse properties ("the properties") that are currently in the BPI structure. In August 2013, Wesfarmers established BPI as a wholly owned, special purpose vehicle to facilitate the sale and leaseback of the properties via a securitised lease transaction. The sale and leaseback was funded primarily from the issuance by BPI of twelve-year senior secured notes to investors. Subject to the independent valuation, Wesfarmers is expected to record a one-off pre-tax profit associated with the transaction of between $80 million and $130 million in the 2025 financial year. The one-off impact to Wesfarmers' earnings reflects the expected fair value uplift associated with the properties and the unwind of the property structure. Wesfarmers will undertake a strategic review of the properties, which will include exploring a range of capital management options once the BPI structure is unwound.
공시 • Dec 21Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million.Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd. The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025.
공시 • Nov 20+ 1 more updateWesfarmers Limited to Report Fiscal Year 2025 Results on Aug 28, 2025Wesfarmers Limited announced that they will report fiscal year 2025 results on Aug 28, 2025
공시 • Sep 03Wesfarmers Limited Announces Resignation of Robert Geoffrey Scott as DirectorWesfarmers Limited announced the resignation of Robert Geoffrey Scott as director. Date of last notice is on 24 May 2024.
공시 • Aug 15Macquarie and Wesfarmers Reportedly Join the Race for $3 Billion I-MED SaleWesfarmers Limited (ASX:WES) and Macquarie Group Limited (ASX:MQG) are the latest names to emerge as a keen competitors for the $3 billion diagnostic imaging business I-MED Holdings Pty Limited, which is about to hit the market. It comes after Wesfarmers is understood to have carried out detailed analysis of I-MED, as it focuses on the healthcare industry for acquisitions. No doubt acquisitions in healthcare will be discussed when Wesfarmers, which owns retail brands including Target, Kmart and Officeworks, reports its full year results on August 29. Meanwhile, Macquarie would look at I-MED through its infrastructure arm Macquarie Asset Management, and is believed to be keen to get a partner to assess the opportunity. DataRoom revealed that Morgan Stanley was about to be hired to sell I-MED, with Bain Capital and Morgan Stanley Infrastructure Partners interested suitors. Jefferies Australia is also now advising. A number of other global private equity firms are also lining up to take a look, say sources.
공시 • Aug 12Private Equity Reportedly Pursues RamsayA European private equity firm is understood to be running the ruler over the $10 billion Ramsay Health Care Limited (ASX:RHC), with an eye to becoming the second group in two years to launch a buyout proposal for the nation's largest private hospital operator. Ramsay last week flagged that it would deliver weaker-than-expected earnings for the full year as it wrote down the value of its European operation. The hospital operator, which is scheduled to release its full-year results on August 30, told the ASX last Monday that its underlying net profit was expected to be in the range of $265 million to $270 million, compared with $278.2 million the previous year. Ramsay was considered a takeover target earlier this year, with the Perth-based conglomerate Wesfarmers known to be running the ruler over the business some time ago. It is understood that Wesfarmers Limited (ASX:WES), which recently appointed Ramsay's former chief operating officer Kate Munnings, to its board carried out extensive and detailed work on a potential buyout of Ramsay and an acquisition of the country's largest diagnostic imaging provider I-MED, which is expected to be put on the block next month for about $3 billion through Morgan Stanley and Jefferies. However, Wesfarmers thought Ramsay would have to be far cheaper before it would make its move - despite Ramsay's share price being at its lowest level in a decade, about a third cheaper than it was after Kohlberg Kravis Roberts bid for the business in 2022. Some think the European suitor may be CVC, while Partners Group, which is also based in Europe, has looked at Australian healthcare company Healius, and EQT could also be an acquirer. Other European funds that invest in healthcare include Permira, PAI and Intermediate Capital. Some think a company with real estate expertise would be the most likely to have interest because of Ramsay's lucrative portfolio of hospital assets in Australia. There's also a view that any deal involving Ramsay would unfold after it has demerged or sold its Ramsay Sante operation in Europe. Ramsay, whose David Thodey-led board recently appointed former Woolworths executive Natalie Davis as chief executive to replace Craig McNally, has been trying to find a solution for that part of the company, which has lagged in performance. Ramsay Health Care owns 52.79% of Ramsay Sante, the second-largest private care provider in Europe, and a sale would help to reduce its $4.7 billion of debt. Buyers are not interested in the whole business, but it could try to sell a stake.
공시 • May 02Wesfarmers Limited Announces Executive ChangesWesfarmers Limited announced that Ian Hansen, Managing Director of Wesfarmers Chemicals, Energy and Fertilisers (WesCEF) has advised of his intention to retire in November 2024. Mr. Hansen will remain with WesCEF and Wesfarmers in an advisory capacity to ensure a smooth transition and provide ongoing support on key projects, including the Group's lithium business, where he will remain Chairman of Covalent Lithium. Mr. Hansen will be succeeded by Aaron Hood, WesCEF's Chief Operating Officer. Prior to his current role Mr. Hood held other senior executive positions within the Group, including Chief Financial Officer of WesCEF and Executive General Manager of Business Development at Wesfarmers. He is also a director of the Covalent Lithium joint venture. Wesfarmers Managing Director Rob Scott said Mr. Hood's skills and experience made him a logical successor to Mr. Hansen. Mr. Hood has been appointed Deputy Managing Director of WesCEF effective 2 May 2024 and will also retain responsibilities as Chief Operating Officer until he commences as the Managing Director of WesCEF in November 2024.
공시 • Apr 24Wesfarmers Reportedly Runs the Ruler over Ramsay Health CareThe $74 billion Australian listed conglomerate Wesfarmers Limited (ASX:WES) is understood to have been carrying out detailed work in recent months, weighing up the merits of buying Ramsay Health Care Limited (ASX:RHC). It is understood that Wesfarmers - which owns Target, Kmart, Officeworks and other industrial and healthcare assets - is interested in securing Ramsay's Australian business. However, with its shares performing strongly and a $74 billion market value, it's not inconceivable that Wesfarmers buys all of the $12 billion private hospital operator and sells off the international assets to other parties. Some believe that the timing could now be right for Wesfarmers to embark on its next major acquisition, after bedding down the 2022 purchase of Priceline pharmacy chain owner Australian Pharmaceutical Industries for $763 million to seed its healthcare unit. Whether it remains serious about a deal remains unclear. Wesfarmers is usually assessing the acquisition of a handful of targets at any given time, and maintains an active mergers and acquisitions team. It has looked at plenty of opportunities in the past before opting to walk away, and can treat targets as simply a due diligence exercise. Another possibility is that it could simply be weighing up a tilt at Ramsay's pharmacy unit, which it has expressed interest in before. Still, Wesfarmers' share price has rallied since the start of this year so it could take advantage of that, while the healthcare sector has been struggling with high costs and staff shortages, dampening the performance of Australian listed stocks trading in the space, including Ramsay. Also weighing in Wesfarmers' favour is the fact that Ramsay's shareholders have been unhappy with the company's performance since Kohlberg Kravis Roberts walked away from a bid in 2022, causing its share price to tumble, and the could be more open to a buyout. The David Thodey-chaired Ramsay is believed to be thinking about a potential exit from its European hospital owner, Ramsay Sante, in which it has a 52.79% stake. DataRoom understands that Wesfarmers has carried out work on all aspects of the Ramsay business, including its real estate, and has been speaking to healthcare funds and industry figures.
공시 • Feb 17Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2023, Payable on March 27, 2024Wesfarmers Limited announced dividend for the six months ended December 31, 2023 of AUD 0.91000000 per share. Record date is February 21, 2024. Ex-date is February 20, 2024. Payment date is March 27, 2024.
공시 • Dec 05+ 2 more updatesWesfarmers Limited, Annual General Meeting, Oct 31, 2024Wesfarmers Limited, Annual General Meeting, Oct 31, 2024.
공시 • Sep 07TPG Capital Reportedly Tests Buyer Interest for the $3.5 Billion-Plus GreencrossSpeculation is mounting that TPG Capital, L.P. is testing buyer interest for the $3.5 billion-plus Petbarn owner Greencross Limited and some are pointing to Wesfarmers Limited (ASX:WES) as the potential suitor. Working on a potential sale of the business, which owns veterinary clinics and a trans-Tasman pet care retail business, is investment bank Jefferies LLC, and there is a view that the $60 billion listed Perth-based Wesfarmers is showing some interest. The question is whether TPG would sell the company as a whole or just the interest that it retained after offloading 45% to AustralianSuper and The Healthcare of Ontario Pension Plan. That deal last year valued the business at $3.5 billion, and since then, Greencross has purchased Habitat Pet Supplies, a Melbourne-based pet store chain with five stores that it plans to merge with its Petbarn and Animates retail business. The logic is all there for Wesfarmers to buy Greencross. The question is whether it would buy off TPG - expected to have overly enthusiastic expectations on price. Yet TPG has already pocketed $1.57 billion through its sell down so perhaps the price tag won't be that large after all. Wesfarmers, which did not comment on whether it was weighing an acquisition, would be familiar with the business given it looked at Greencross when Credit Suisse and Morgan Stanley ran a sale process in 2021.
공시 • Aug 25Wesfarmers Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on October 5, 2023Wesfarmers Limited announced dividend of AUD 1.03 per share for the six months ended June 30, 2023. Ex-date is August 30, 2023. Record date is August 31, 2023. Payment date is October 5, 2023.
공시 • Jun 27Wesfarmers Limited Announces Management ChangesWesfarmers Limited announced that Vicki Robinson has advised of her intention to retire as Company Secretary, effective 30 October 2023, to focus on non-executive opportunities. Ms. Robinson will be succeeded as Company Secretary and as a member of the Wesfarmers Leadership Team by Sheldon Renkema. Mr. Renkema joined Wesfarmers in 2007 and is currently General Manager of Business Development for Wesfarmers Chemicals, Energy and Fertilisers, having previously held senior positions leading the corporate and retail legal teams within the Wesfarmers Corporate Solicitors Office. Wesfarmers Managing Director, Rob Scott, thanked Ms. Robinson for her significant contribution to Wesfarmers over the last 20 years and congratulated Mr. Renkema on his appointment.
공시 • May 09Wesfarmers Reportedly Among Suitors for Alinta AssetsWesfarmers Limited (ASX:WES) is understood to be among the suitors looking to acquire Alinta Energy Pty Limited's West Australian assets. First-round bids for the assets are due on May 12 in the Goldman Sachs-run competition. Sources say the motivation of the $58 billion listed conglomerate is to gain additional sources of power, and it would be compelled by the renewable energy component of the offering. Several parties are believed to be lining up for Alinta's business, including Pacific Equity Partners, which owns Zenith Energy, and the business interests of Gina Rinehart, owner of Hancock Energy and Hancock Prospecting. DataRoom understands that working with Hancock on Alinta is Highbury Partnership, which advised on the $4 billion acquisition by Chow Tai Fook of Alinta Energy in 2017 from TPG Capital. Also in the competition are private equity firm EQT Partners AB and Macquarie Group Limited (ASX:MQG), which would partner with another suitor, likely to be BP, which is also looking. Macquarie already partners with BP on its Australian Renewable Energy Hub in the Pilbara. Queensland Investment Corporation is expected to be looking through its Pacific Energy business, while CKI is believed to be bidding through Energy Developments, although the Chinese-owned group may face opposition from the Foreign Investment Review Board. There is also a view that billionaire Andrew Forrest will be around the hoop - either through his Squadron Energy or through Fortescue Metals. Investment bank Citi is mandated by a party, and sources have been pointing to either QIC or Brookfield. Based on the level of interest, some think private equity firms, and possibly APA, will not be competitive on price, going up against parties with a cheaper cost of capital.
공시 • Feb 15+ 1 more updateWesfarmers Limited, Annual General Meeting, Oct 26, 2023Wesfarmers Limited, Annual General Meeting, Oct 26, 2023.
공시 • Jan 18Wesfarmers Limited to Report Q2, 2023 Results on Feb 15, 2023Wesfarmers Limited announced that they will report Q2, 2023 results on Feb 15, 2023
공시 • Oct 19Wesfarmers Limited to Report Fiscal Year 2023 Results on Aug 25, 2023Wesfarmers Limited announced that they will report fiscal year 2023 results on Aug 25, 2023